Oral tranexamic acid after total shoulder replacement to reduce bleeding and help early recovery.
Official title: Evaluating the Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty: A Randomized Control Trial
Run by University of Alabama at Birmingham · NCT06902714 · Data updated 2026-11-12
This Phase 3 study will test whether taking oral tranexamic acid after a total shoulder replacement helps adults 18–79 have less bleeding and better short-term recovery compared with a placebo.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 79 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Status | Recruiting |
| Started | April 20, 2026 |
| Main results expected | July 2028 |
| Study ends | December 2030 |
| Registry record updated | April 28, 2026 |
| Trial ID | NCT06902714 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–79 having a primary total shoulder replacement who do not have active cancer, recent clotting or stroke history, significant heart disease, pregnancy or breastfeeding, allergy to TXA, current tobacco use, or use of anticoagulants other than aspirin are appropriate candidates.
✕Probably not a fit
Patients with a history of venous thromboembolism, recent stroke, significant cardiac disease, active cancer, pregnancy or nursing, TXA allergy, current tobacco use, or who take anticoagulants other than aspirin are excluded and unlikely to receive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 3 interventional study at the University of Alabama at Birmingham gives patients undergoing primary total shoulder arthroplasty an extended postoperative course of either oral tranexamic acid or a matching placebo. Participants are skeletally mature adults aged 18–79 and those with active cancer, prior venous thromboembolism or stroke, significant heart disease, pregnancy or nursing, TXA allergy, current tobacco use, or use of anticoagulants other than aspirin are excluded. The trial focuses on short-term postoperative clinical outcomes, including measures related to bleeding, hemoglobin, wound complications, and early functional recovery. Results will show whether an extended oral TXA regimen improves early recovery after shoulder replacement compared with placebo.
Why it matters
Potential benefit: If successful, taking oral tranexamic acid after shoulder replacement could reduce postoperative bleeding and speed early recovery.
How similar studies have gone: Previous work in hip and knee arthroplasty and some shoulder procedures has shown that tranexamic acid can reduce blood loss and transfusion needs, but extended postoperative oral regimens after shoulder replacement are less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Skeletally mature patients (ages 18-79) undergoing primary total shoulder arthroplasty Exclusion Criteria: * Patients with Cancer, venous thromboembolism, stroke, heart disease, pregnant or nursing, allergic to TXA, current tobacco use, anticoagulants other than aspirin.
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting
Study contacts
- Principal investigator: Walter Smith, MD — University of Alabama at Birmingham
- Study coordinator: Walter Smith
- Email: waltersmith@uabmc.edu
- Phone: 205-930-8554
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Does nutrition affect recovery after shoulder replacement with virtual reality–enhanced rehab?
This project will test whether better nutritional status helps adults 60 and older recover function faster after elective shoulder surgery when they use virtual reality–assisted rehabilitation.
-
Lower local anesthetic concentration and rebound shoulder pain after shoulder arthroplasty
This study tests whether using a lower concentration of local anesthetic in a nerve block reduces rebound pain 24 hours after shoulder replacement surgery.
-
Comparing early and delayed rehabilitation after shoulder surgery for fractures
This study is testing whether starting physical therapy two weeks or six weeks after shoulder surgery helps patients recover better from their fractures.
-
Post-incision antimicrobial washes to reduce C. acnes after shoulder replacement
This trial will test whether applying different antimicrobial washes after the first incision lowers C. acnes growth in adults having primary shoulder replacement.
-
Registry for shoulder replacement outcomes
This study is collecting information from patients who have shoulder replacement surgery to see how well the new shoulder system works over time.
-
Registry for shoulder replacement surgeries
This study is gathering information from people who are having shoulder replacement surgeries to see how well these procedures work and how they affect patients over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.